Back to Results
First PageMeta Content
Melanoma / Vemurafenib / BRAF / PDK1 / Pyruvate dehydrogenase kinase / Mammalian target of rapamycin / Targeted therapy / Biology / Medicine / Chemistry


Opportunity Combination of mutant BRAF inhibitor with Pyruvate Dehydrogenase Kinase isoform 1 (PDK-1) inhibitor for treatment of melanoma/ overcoming BRAF inhibitor resistance •
Add to Reading List

Document Date: 2015-06-08 08:44:48

Open Document

File Size: 257,71 KB

Share Result on Facebook
UPDATE